GGrantIndex
← Leaderboards

Stephen K. Van Den Eeden

Kaiser Foundation Research Institute

$13,042,835
Attributed
$19,897,800
Total exposure
11
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY200922
$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$19,897,800 · 11

By mechanism

R01$11,178,535 · 7
K12$3,970,862 · 1
U01$1,915,126 · 1
P50$1,835,824 · 1
RC1$997,453 · 1

Top collaborators

Most similar at Kaiser Foundation Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Cohort

Research focus

CohortCaliforniaAreaProgramsLifeInnovationEpidemiologyBaseDiagnosisResourcesCollaborationsCaringCostFutureFollow-UpEpidemiology StudyData SetUrologicQuality Of LifeComputerized Medical RecordProspectiveDiabetes MellitusRecording Of Previous EventsIncidence

Grant awards (45)

UCSF-Kaiser Urological Epidemiology Research Career Development Program$612,666
K12 · FY2022 · DK
UCSF-Kaiser Urological Epidemiology Research Career Development Program$557,956
K12 · FY2021 · DK
Air Pollutants and Cardiovascular Risk: Investigating Thresholds with Pooled Cohorts and Electronic Health Records$604,215
R01 · FY2020 · ES
UCSF-Kaiser Urological Epidemiology Research Career Development Program$517,353
K12 · FY2020 · DK
UCSF-Kaiser Urological Epidemiology Research Career Development Program$206,550
K12 · FY2020 · DK
Air Pollutants and Cardiovascular Risk: Investigating Thresholds with Pooled Cohorts and Electronic Health Records$615,555
R01 · FY2019 · ES
UCSF-Kaiser Urological Epidemiology Research Career Development Program$517,353
K12 · FY2019 · DK
Chronic Pancreatitis, Diabetes and Pancreatic Cancer: A Prospective Approach$321,843
U01 · FY2019 · DK · contact PI
Susceptibility Genes for Erectile Dysfunction$245,331
R01 · FY2019 · DK
Air Pollutants and Cardiovascular Risk: Investigating Thresholds with Pooled Cohorts and Electronic Health Records$634,496
R01 · FY2018 · ES
UCSF-Kaiser Urological Epidemiology Research Career Development Program$518,800
K12 · FY2018 · DK
Chronic Pancreatitis, Diabetes and Pancreatic Cancer: A Prospective Approach$394,420
U01 · FY2018 · DK · contact PI
Air Pollutants and Cardiovascular Risk: Investigating Thresholds with Pooled Cohorts and Electronic Health Records$687,881
R01 · FY2017 · ES
UCSF-Kaiser Urological Epidemiology Research Career Development Program$519,092
K12 · FY2017 · DK
Chronic Pancreatitis, Diabetes and Pancreatic Cancer: A Prospective Approach$399,658
U01 · FY2017 · DK · contact PI
Susceptibility Genes for Erectile Dysfunction$271,043
R01 · FY2017 · DK
UCSF-Kaiser Urological Epidemiology Research Career Development Program$521,092
K12 · FY2016 · DK
Chronic Pancreatitis, Diabetes and Pancreatic Cancer: A Prospective Approach$403,878
U01 · FY2016 · DK · contact PI
Susceptibility Genes for Erectile Dysfunction$252,005
R01 · FY2016 · DK
TREATMENT DECISIONS AND PATIENT REPORTED OUTCOMES IN LOW RISK PROSTATE CANCER$570,418
R01 · FY2015 · CA
Genetic Epidemiology of Prostate Cancer Risk and Progression$440,611
R01 · FY2015 · CA
Chronic Pancreatitis, Diabetes and Pancreatic Cancer: A Prospective Approach$395,327
U01 · FY2015 · DK · contact PI
Epidemiology of Human Narcolepsy$370,723
P50 · FY2015 · NS · contact PI
TREATMENT DECISIONS AND PATIENT REPORTED OUTCOMES IN LOW RISK PROSTATE CANCER$668,484
R01 · FY2014 · CA
Adult Life Predictors of Genitourinary Disorders$464,322
R01 · FY2014 · DK · contact PI
Epidemiology of Human Narcolepsy$367,725
P50 · FY2014 · NS · contact PI
Genetic Epidemiology of Prostate Cancer Risk and Progression$358,978
R01 · FY2014 · CA
TREATMENT DECISIONS AND PATIENT REPORTED OUTCOMES IN LOW RISK PROSTATE CANCER$564,945
R01 · FY2013 · CA
Genetic Epidemiology of Prostate Cancer Risk and Progression$523,491
R01 · FY2013 · CA
Adult Life Predictors of Genitourinary Disorders$490,433
R01 · FY2013 · DK · contact PI
Epidemiology of Human Narcolepsy$385,298
P50 · FY2013 · NS · contact PI
Cardiovascular and Prostatic Safety of Testosterone Therapy in Aging Males$203,040
R01 · FY2013 · AG
Cardiovascular and Prostatic Safety of Testosterone Therapy in Aging Males$33,380
R01 · FY2013 · AG
TREATMENT DECISIONS AND PATIENT REPORTED OUTCOMES IN LOW RISK PROSTATE CANCER$619,221
R01 · FY2012 · CA
Adult Life Predictors of Genitourinary Disorders$437,212
R01 · FY2012 · DK · contact PI
Epidemiology of Human Narcolepsy$412,808
P50 · FY2012 · NS · contact PI
Cardiovascular and Prostatic Safety of Testosterone Therapy in Aging Males$218,839
R01 · FY2012 · AG
TREATMENT DECISIONS AND PATIENT REPORTED OUTCOMES IN LOW RISK PROSTATE CANCER$641,072
R01 · FY2011 · CA
Adult Life Predictors of Genitourinary Disorders$410,804
R01 · FY2011 · DK · contact PI
Epidemiology of Human Narcolepsy$299,270
P50 · FY2011 · NS · contact PI
Adult Life Predictors of Genitourinary Disorders$585,932
R01 · FY2010 · DK · contact PI
Cost-Effectiveness of Hormonal Therapy for Clinically Localized Prostate Cancer$497,496
RC1 · FY2010 · CA · contact PI
Cost-Effectiveness of Hormonal Therapy for Clinically Localized Prostate Cancer$499,957
RC1 · FY2009 · CA · contact PI
AIR POLLUTION, RACE, SES &ASTHMA HOSPITALIZATION RISK$307,313
R01 · FY2001 · ES
AIR POLLUTION, RACE, SES &ASTHMA HOSPITALIZATION RISK$329,514
R01 · FY2000 · ES